Contributors |
|
ix | |
|
1 Optical coherence tomography imaging for stent planning |
|
|
1 | (28) |
|
|
|
|
1 | (1) |
|
|
2 | (1) |
|
1.3 Preintervention OCT imaging |
|
|
3 | (11) |
|
1.4 Postintervention OCT imaging |
|
|
14 | (7) |
|
1.5 Potential clinical impact of OCT use for PCI planning and guidance |
|
|
21 | (8) |
|
|
23 | (6) |
|
2 OCT imaging for assessment of plaque modification |
|
|
29 | (14) |
|
|
|
|
29 | (1) |
|
2.2 Plain ordinary balloon and drug-eluting balloon angioplasty |
|
|
29 | (14) |
|
|
42 | (1) |
|
3 OCT for plaque modification |
|
|
43 | (16) |
|
|
3.1 Plaque modification before coronary artery stenting using cutting/scoring balloon |
|
|
43 | (1) |
|
3.2 Cutting and scoring balloons |
|
|
43 | (2) |
|
3.3 Trial results with cutting or scoring balloon plaque pretreatment |
|
|
45 | (1) |
|
3.4 Patient's clinical cases using cutting and scoring plaque pretreatment |
|
|
46 | (13) |
|
|
58 | (1) |
|
4 OCT for stent optimization |
|
|
59 | (16) |
|
|
|
|
|
59 | (1) |
|
4.2 Utilization of OCT for vessel preparation |
|
|
59 | (1) |
|
4.3 OCT for defining stent length and diameter |
|
|
60 | (4) |
|
4.4 OCT for side branch protection |
|
|
64 | (8) |
|
|
72 | (3) |
|
|
72 | (3) |
|
5 OCT for left main assessment |
|
|
75 | (10) |
|
|
|
75 | (1) |
|
5.2 Safety of FD-OCT for ULM Disease |
|
|
75 | (2) |
|
5.3 FD-OCT Measurements for ULM Disease |
|
|
77 | (1) |
|
5.4 Feasibility of FD-OCT for ULM Disease |
|
|
78 | (4) |
|
|
82 | (3) |
|
|
82 | (3) |
|
6 Optical coherence tomography for late stent failure |
|
|
85 | (12) |
|
|
|
|
|
85 | (1) |
|
|
85 | (4) |
|
6.3 Case report: In-stent restenosis |
|
|
89 | (2) |
|
|
91 | (6) |
|
|
94 | (3) |
|
7 OCT assessment in spontaneous coronary artery dissection |
|
|
97 | (14) |
|
|
|
|
7.1 Spontaneous coronary artery dissection |
|
|
97 | (5) |
|
7.2 Role of OCT in the diagnosis and management of spontaneous coronary artery dissection |
|
|
102 | (3) |
|
|
105 | (2) |
|
|
107 | (1) |
|
|
107 | (4) |
|
|
107 | (4) |
|
8 Optical coherence tomography assessment for cardiac allograft vasculopathy after heart transplantation |
|
|
111 | (12) |
|
|
|
|
111 | (1) |
|
8.2 Screening and diagnosing CAV |
|
|
112 | (1) |
|
|
112 | (3) |
|
8.4 OCT utilization post--heart transplantation |
|
|
115 | (4) |
|
|
119 | (1) |
|
|
119 | (4) |
|
|
119 | (4) |
|
9 OCT assessment out of the coronary arteries |
|
|
123 | (12) |
|
|
|
|
|
|
123 | (1) |
|
9.2 History of intravascular imaging |
|
|
123 | (1) |
|
9.3 Optical coherence tomography |
|
|
124 | (2) |
|
9.4 Clinical applications of OCT in the peripheral vasculature |
|
|
126 | (6) |
|
|
132 | (3) |
|
|
133 | (2) |
|
10 Optical coherence tomography for the assessment of bioresorbable vascular scaffolds |
|
|
135 | (10) |
|
|
|
|
|
135 | (1) |
|
10.2 Optical coherence tomography assessment before BVS implantation |
|
|
136 | (2) |
|
10.3 Optical coherence tomography assessment after BVS implantation |
|
|
138 | (1) |
|
10.4 Optical coherence tomography assessment for BVS follow-up |
|
|
139 | (6) |
|
|
142 | (1) |
|
|
142 | (3) |
|
11 ILUMIEN OPTIS Mobile and OPTIS Integrated Technology Overview |
|
|
145 | (18) |
|
|
|
|
145 | (3) |
|
11.2 ILUMIEN OPTIS Mobile System |
|
|
148 | (2) |
|
11.3 OPTIS Integrated System |
|
|
150 | (5) |
|
11.4 OCT application software |
|
|
155 | (3) |
|
11.5 Angio coregistration software |
|
|
158 | (2) |
|
|
160 | (3) |
|
|
160 | (3) |
|
|
163 | (18) |
|
|
|
|
|
163 | (1) |
|
12.2 FastView imaging catheter |
|
|
163 | (3) |
|
12.3 LUNAWAVE OFDI imaging console |
|
|
166 | (6) |
|
12.4 Case report: Usefulness of OFDI-guided PCI for the separated proximal and mid--left anterior descending artery lesions |
|
|
172 | (5) |
|
|
12.5 Case report: Usefulness of 3D OFDI for bifurcation PCI |
|
|
177 | (4) |
|
|
|
179 | (1) |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
180 | (1) |
|
13 OCT imaging acquisition |
|
|
181 | (8) |
|
|
|
|
|
|
181 | (1) |
|
|
181 | (1) |
|
|
182 | (1) |
|
13.4 Flushing parameters: Recommended injection setting |
|
|
183 | (1) |
|
13.5 Pitfalls and limitations |
|
|
183 | (4) |
|
|
187 | (2) |
|
|
187 | (2) |
Appendix: Intravascular bioresorbable vascular scaffold optimization technique |
|
189 | (8) |
|
|
Index |
|
197 | |